Platelet Utilization in a University Hospital

JAMA: The Journal of the American Medical Association

Volumn 259, Issue 16, 1988, Pages 2414-2418

  Mccullough, Jeffrey ^a   Steeper, Theresa A ^b   Connelly, Donald P ^b   Jackson, Brooks ^a   Huntington, Sally ^c   Scott, Edward P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Department of Laboratory Medicine and Pathology ^*  (United States)

^c Quality Assurance Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; ECONOMIC ASPECT; HUMAN; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; UNIVERSITY HOSPITAL;

ADULT; BLOOD TRANSFUSION; CHILD, PRESCHOOL; HEMATOLOGIC DISEASES; HEMORRHAGE; HOSPITALS, UNIVERSITY; HUMAN; MINNESOTA; PLATELET COUNT; PLATELET TRANSFUSION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023933175     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03720160034026     Document Type: Article

References (41)

1. Blood Services Operations Reports. Washington, DC, American Red Cross, 1980-1985.
2. Menitove JE, McElligott MC, Aster RH: Where have all the platelets gone? A strategy for monitoring platelet usage. Wis State Med J 1982;81:11-13.
3. Gaydos LA, Freireich EJ, Mantel N: The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962;266:905-909.
4. Aderka D, Praff G, Santo M, et al.: Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy. Am J Med Sci 1986;291:147-151.
5. Roy AJ, Jaffe N, Djerassi I: Prophylactic platelet transfusions in children with acute leukemia: A dose-response study. Transfusion 1973; 13:283-290.
6. Higby DJ, Cohen E, Holland JF, et al.: The prophylactic treatment of thrombocytopenic leukemia patients with platelets: A double blind study. Transfusion 1974;14:440-446.
7. Solomon J, Bofenkamp T, Fahey JL, et al.: Platelet prophylaxis in acute nonlymphocytic leukemia. Lancet 1978;1:267.
8. Murphy S, Litwin S, Herring LM, et al.: Indications for platelet transfusion in children with acute leukemia. Am J Hematol 1982;12:347-351.
9. Slichter SJ: Controversies in platelet transfusion therapy. Ann Rev Med 1980;31:509-540.
10. Ilett SJ, Lilleyman JS: Platelet transfusion requirements of children with newly diagnosed lymphoblastic leukaemia. Acta Haematol 1979;62:86-89.
11. Slichter S, Harker LA: Thrombocytopenia: Mechanisms and management of defects in platelet production. Clin Haematol 1978;7:523-526.
12. Harker LA, Slichter SJ: The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972;287:155-159.
13. Eknoyan G, Wacksman SJ, Glueck HI, et al.: Platelet function in renal failure. N Engl J Med 1969;280:677-681.
14. Steiner RW, Coggins C, Carvalho ACA: Bleeding time in uremia: A useful test to assess clinical bleeding. Am J Hematol 1979;7:107-117.
15. Lindsay RM, Friesen M, Koens F, et al.: Platelet function in patients on long-term peritoneal dialysis. Clin Nephrol 1976;6:335-339.
16. Janson PA, Jubelirer SJ, Weinstein MJ, et al.: Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 1980;303:1318-1322.
17. Platelet transfusion therapy, CONSENSUS CONFERENCE. JAMA 1987;257:1777-1780.
18. Cardamone JM, Edson JR, McArther JR, et al.: Abnormalities of platelet function in the myeloproliferative disorders. JAMA 1972;221:270-276.
19. Freeman G, Buckley ES: Serum polysaccharide and fever in thrombocytopenic bleeding of leukemia. Blood 1954;9:586-594.
20. Brown CH, Natelson EA, Bradshaw W, et al.: The hemostatic defect produced by carbenicillin. N Engl J Med 1974;291:265-270.
21. Haburchak DR, Head DR, Everett ED: Postoperative hemorrhage associated with carbenicillin administration. Am J Surg 1977;134:630-634.
22. Shattil SJ, Bennett JS, McDonough M, et al.: Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest 1980;65:329-337.
23. Brown CH, Natelson EA, Bradshaw W, et al.: Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob Agents Chemother 1975;7:652-657.
24. Johnson GJ, Rao GHR, White JG: Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Am J Pathol 1978;91:85-106.
25. Cazenave JP, Packham MA, Guccione MA, et al.: Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proc Soc Exp Biol Med 1973;142:159-163.
26. Weitekamp MR, Aber RC: Prolonged bleeding times and bleeding diathesis associated with moxa-lactam administration. JAMA 1983;249:69-71.
27. Sattler FR, Weitekamp MR, Ballard JO: Potential for bleeding with the new beta-lactam antibiotics. Ann Intern Med 1986;105:924-931.
28. Mielke CH, Kaneshiro MM, Maher IA, et al.: The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969;34:204-215.
29. O’Brien JR, Finch W, Clark E: A comparison of an effect of different anti-inflammatory drugs on human platelets. J Clin Pathol 1970;23:522-525.
30. Nelson WR, Taylor GA: In vitro inhibition of endotoxin induced platelet aggregation with hydrocortisone sodium succinate (Solu-Cortef). Scand J Haematol 1975;15:35-46.
31. O’Brien JR, Oxon DM: Effects of salicylates on human platelets. Lancet 1968;1:779-783.
32. Weiss HJ: Acquired qualitative platelet disorders, in Williams WJ (ed): Haematology, ed 2. New York, McGraw-Hill International Book Co, 1977, pp 1377-1384.
33. Swanson JL, Mann EW, Condie RM, et al.: Resolution of crossmaching problems associated with patients receiving anti-lymphocyte globulin. Transfusion 1984;24:141-143.
34. Strauss RG: The risk of thrombocytopenia and the standard uses of platelet transfusions. Plasma Ther Transfus Technol 1986;7:279-283.
35. Foley ME, McNicol GP: An in vitro study of acidosis, platelet function, and perinatal cerebral intraventricular haemorrhage. Lancet 1977;1:1230-1232.
36. Freireich EA, Kliman A, Gaydos L: Response to repeated platelet transfusion from the same donor. Ann Intern Med 1963;59:277-287.
37. Cohen P, Gardner FH: Thrombocytopenia as a laboratory sign and complication of gram-negative bacteremic infection. Arch Intern Med 1966;117: 113-124.
38. Gaetano G, Donati M, Garattin S: Drugs affecting platelet function tests, their effects of haemostasis and surgical bleeding. Thromb Diath Haemorrh 1975;34:284-289.
39. Penner JA: Blood component therapy for patients with coagulation disorders, in Petz LD, Swisher SN (eds): Clinical Practice of Blood Transfusion. New York, Churchill Livingstone Inc, 1981, p 514-541.
40. Harker LA, Malpass TW, Branson HE, et al.: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha granule release. Blood 1980;56:824-834.
41. Tomasulo PA: Platelet transfusions for nonmalignant diseases, in Petz LD, Swisher SN (eds): Clinical Practice of Blood Transfusion. New York, Churchill Livingstone Inc, 1981, pp 530-548.